'Un­heard-of speed­s': Trump, new­ly warmed up to bio­phar­ma, prais­es in­dus­try's coro­n­avirus re­sponse at White House meet­ing

Speed is of the essence when it comes to de­vel­op­ing vac­cines and ther­a­peu­tics for the new coro­n­avirus. Es­pe­cial­ly if you are brief­ing Pres­i­dent Don­ald Trump.

“What’s your tim­ing here?” was Trump’s go-to ques­tion af­ter he lis­tened to each of the 10 bio­phar­ma ex­ec­u­tives who con­vened in the White House Mon­day af­ter­noon with the coro­n­avirus task force led by VP Mike Pence.

The usu­al sus­pects were present: Stéphane Ban­cel of Mod­er­na, which has shipped off its mR­NA vac­cine for a Phase I study at the NIH; Len Schleifer of Re­gen­eron, in the hunt for an­ti­bod­ies; Gilead’s Daniel O’Day, there to dis­cuss the two Phase III tri­als his com­pa­ny has start­ed for a close­ly watched an­tivi­ral; and Glax­o­SmithK­line CEO Em­ma Walm­s­ley, to­geth­er with rep­re­sen­ta­tives of J&J and Sanofi, rep­re­sent­ing the tra­di­tion­al vac­cine mak­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER